CSCO breast cancer management guidelines 2022: Australian perspective
Translational Breast Cancer Research · 2022-10 · 3 · 36-36
DOI: 10.21037/tbcr-22-46 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Breast Cancer Research, 2022-10. Verfasst von Chen Han Yong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Lyell McEwin Hospital, Adelaide, South Australia, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Lyell McEwin Hospital, Adelaide, South Australia, Australia.
- Department of Breast & Endocrine Surgery, Lyell McEwin and Modbury Hospitals, Adelaide, South Australia, Australia.
- The University of Adelaide, Adelaide, South Australia, Australia.
Zitieren
APA
Yong, C. H., Gupta, A., & Joshi, R. (2022). CSCO breast cancer management guidelines 2022: Australian perspective. Translational Breast Cancer Research, 3, 36-36. https://doi.org/10.21037/tbcr-22-46
Vancouver
Yong CH, Gupta A, Joshi R. CSCO breast cancer management guidelines 2022: Australian perspective. Translational Breast Cancer Research. 2022;3:36-36. doi:10.21037/tbcr-22-46
BibTeX
@article{Yong2022,
author = {Yong, Chen Han and Gupta, Anurag and Joshi, Rohit},
title = {CSCO breast cancer management guidelines 2022: Australian perspective},
journal = {Translational Breast Cancer Research},
year = {2022},
volume = {3},
pages = {36--36},
doi = {10.21037/tbcr-22-46}
}
EUVIMED